Table 2.
qRT-PCR analysis of genes using the frontal cortex (the same genes in Table 1)
| Symbol | Definition | n | KOS/WS (vs. WS) % | WPCP/WS (vs. WS) % | KOPCP/KOS % | (vs. WPCP/WS) |
|---|---|---|---|---|---|---|
|
Significantly changed gene expressions induced by PCP of wild-type mice
| ||||||
|
Fos |
FBJ osteosarcoma oncogene |
4 |
89 ± 7 |
271 ± 16 ** |
179 ± 5 |
c |
|
Fosb |
FBJ osteosarcoma oncogene B (Fosb) |
3 |
98 ± 7 |
246 ± 69 ** |
134 ± 19 |
a |
|
Ddit4 |
DNA-damage-inducible transcript 4 (REDD1) |
3 |
112 ± 5 |
200 ± 8 ** |
164 ± 4 |
b |
|
Egr4 |
early growth response 4 |
4 |
107 ± 19 |
164 ± 56 ** |
86 ± 3 |
b |
|
Tsc22d3 |
TSC22 domain family, member 3, transcript variant 1 (DSIPI) |
4 |
100 ± 7 |
209 ± 24 * |
190 ± 15 |
a |
|
Gadd45g |
growth arrest and DNA-damage-inducible 45 γ |
4 |
103 ± 2 |
189 ± 25 * |
146 ± 7 |
a |
|
Cfp |
complement factor properdin (Properdine) |
4 |
105 ± 19 |
151 ± 9 ** |
126 ± 20 |
a |
|
Slc2a1 |
solute carrier family 2 (GLUT1) |
4 |
93 ± 5 |
149 ± 8 ** |
150 ± 5 |
a |
|
Txnip |
thioredoxin interacting protein, transcript variant 1 |
4 |
106 ± 8 |
143 ± 16 ** |
126 ± 10 |
a |
|
Bag-3 |
Bcl2-associated athanogene 3 |
4 |
91 ± 6 |
142 ± 6 ** |
128 ± 6 |
a |
|
Pglyrp1 |
peptidoglycan recognition protein 1 (PGRP-S) |
3 |
93 ± 5 |
139 ± 12 ** |
128 ± 12 |
a |
|
Arrdc |
arrestin domain containing 3 (mKIAA1376) |
3 |
110 ± 1 |
136 ± 14 * |
115 ± 14 |
a |
|
Rgc32 |
RIKEN cDNA 1190002H23 gene |
4 |
97 ± 6 |
131 ± 7 * |
123 ± 6 |
a |
|
Significantly changed gene expressions induced by PCP of NR2D KO mice
| ||||||
| Egr1 | early growth response 1(zif-268) | 4 | 94 ± 8 | 87 ± 8 | 67 ± 3 | a |
Data are expressed as the mean percentage ± SEM relative to the saline treated controls.
Compared to WS controls; *, p <0.05. **, p <0.01.
Compared to WS controls; *, p <0.05. **, p <0.01. WPCP vs. KOPCP; a, not significant. b, p <0.05. c, p <0.01.